• Explore /
  • Poster
  • / A phase Ib study exploring the combination of everolimus and dovitinib in VEGF-refractory clear cell renal cancer.

A phase Ib study exploring the combination of everolimus and dovitinib in VEGF-refractory clear cell renal cancer.

Abstract Poster

Authors

null

Amanda Marie Fitzpatrick

Barts Cancer Institute, London, United Kingdom

Amanda Marie Fitzpatrick , Michelle Greenwood , Abigail Foreshew , Jude Nixon , Anju Sahdev , Naveed Sarwar , Louise Lim , Robert J. Jones , Simon Chowdhury , Simon J. Crabb , Thomas Powles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT01714765

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 531)

DOI

10.1200/jco.2014.32.4_suppl.531

Abstract #

531

Poster Bd #

J6

Abstract Disclosures

Similar Posters

First Author: Sven Lundstam

Poster

2013 Genitourinary Cancers Symposium

Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer.

Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer.

First Author: Thomas Powles

First Author: Geoffrey Johnson

First Author: Mark H. O'Hara